Long term survival of advanced hepatoid adenocarcinoma of lung secondary to idiopathic pulmonary fibrosis: a case report

Long term survival of advanced hepatoid adenocarcinoma of lung secondary to idiopathic pulmonary fibrosis: a case report

BackgroundAlpha-fetoprotein (AFP)-producing hepatoid adenocarcinoma of lung (HAL) is a rare type of lung cancer, with its characteristics being not yet fully clarified. We recently encountered a case of HAL combined with idiopathic pulmonary fibrosis (IPF), which has never been reported.Case present...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xiaoli Wang, Nan Wei, Huizhen Yang, Xiaoyan Wang, Xiaoju Zhang, Qianqian Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-02-01
Series:	Frontiers in Oncology
Subjects:	hepatoid adenocarcinoma lung cancer idiopathic pulmonary fibrosis alpha-fetoprotein immune checkpoint inhibitor
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1487334/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Primary pancreatic hepatoid carcinoma: A case report
by: Shizheng Mi, et al.
Published: (2025-02-01)

Case report: Chemotherapy plus sintilimab for the treatment of gastroesophageal junction hepatoid adenocarcinoma with liver metastasis: a case study with literature review
by: Genlin Lu, et al.
Published: (2025-01-01)

Primary Pancreatic Hepatoid Carcinoma: A Case Report and Literature Review
by: Tyng-Wei Yang, et al.
Published: (2023-07-01)

Genetic variation reveals the therapeutic potential of BRSK2 in idiopathic pulmonary fibrosis
by: Zhe Chen, et al.
Published: (2025-01-01)

Autoimmune hepatitis with abnormally high level of serum alpha-fetoprotein (Clinical case)
by: A. O. Bueverov, et al.
Published: (2010-02-01)

Identification and Analysis of Key Immune- and Inflammation-Related Genes in Idiopathic Pulmonary Fibrosis
by: Tan Y, et al.
Published: (2025-02-01)

Machine learning potential predictor of idiopathic pulmonary fibrosis
by: Chenchun Ding, et al.
Published: (2025-01-01)

Quality of life in idiopathic pulmonary fibrosis in Latin American countries
by: H. Aguilar-Duran, et al.
Published: (2025-01-01)

Molecular genetics of idiopathic pulmonary fibrosis
by: R. N. Mustafin
Published: (2022-06-01)

AFP shields hepatocellular carcinoma from macrophage phagocytosis by regulating HuR-mediated CD47 translocation in cellular membrane
by: Yinglian Pan, et al.
Published: (2025-02-01)

Jinbei oral liquid for idiopathic pulmonary fibrosis: a randomized placebo-controlled trial
by: Aijun Zhang, et al.
Published: (2025-01-01)

Treatment approaches for idiopathic retroperitoneal fibrosis: a systematic review with meta-analysis
by: Annik Steimer, et al.
Published: (2025-02-01)

Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B
by: Qianqian Ma, et al.
Published: (2025-02-01)

Regulatory T Cell Phenotype Related to Cytokine Expression Patterns in Post‐COVID‐19 Pulmonary Fibrosis and Idiopathic Pulmonary Fibrosis
by: Sara Gangi, et al.
Published: (2025-01-01)

Signet ring cell gastric adenocarcinoma “Linitis Plastica” Masquerading as retroperitoneal fibrosis: A report of two co-existing uncommon entities
by: Kapil Chaudhary, et al.
Published: (2018-01-01)

A novel scoring system proposal to guide treatment of dogs with hepatoid gland tumors
by: Lorella Maniscalco, et al.
Published: (2025-02-01)

Preoperative serum glutathione reductase activity and alpha-fetoprotein level are associated with early postoperative recurrence of hepatocellular carcinoma
by: Shen Lihong, et al.
Published: (2025-02-01)

Idiopathic pulmonary fibrosis is a risk factor for cardiovascular disease: potential role of KL-6 and systemic inflammation
by: Mohamed F. AbdelGhany, et al.
Published: (2025-01-01)

Fetal Sacrococcygeal Teratoma: A Case Report of a Giant Tumor with an Excellent Outcome
by: Anna Kornete, et al.
Published: (2023-11-01)

Contribution of cuproptosis and immune-related genes to idiopathic pulmonary fibrosis disease
by: Chengji Jin, et al.
Published: (2025-02-01)

METTL14-mediated m6A modification of DDIT4 promotes its mRNA stability in aging-related idiopathic pulmonary fibrosis
by: Dan Li, et al.
Published: (2025-12-01)

Treatable traits in idiopathic pulmonary fibrosis: focus on respiratory tract infections—a systematic review and a meta-analysisResearch in context
by: Zsombor Matics, et al.
Published: (2025-01-01)

Identifying health risk determinants and molecular targets in patients with idiopathic pulmonary fibrosis via combined differential and weighted gene co-expression analysis
by: Abu Tayab Moin, et al.
Published: (2025-01-01)

Commonly prescribed medications and risk of pneumonia and all-cause mortality in people with idiopathic pulmonary fibrosis: a UK population-based cohort study
by: Ann D. Morgan, et al.
Published: (2025-01-01)

Skin microbiome differences in pancreatic adenocarcinoma, other cancers, and healthy controls: a pilot study
by: Taylor Davis, et al.
Published: (2025-02-01)

PIVKA-II as a surrogate biomarker for therapeutic response in Non-AFP-secreting hepatocellular carcinoma
by: San-Chi Chen, et al.
Published: (2025-02-01)

PRDX2 induces tumor immune evasion by modulating the HDAC3-Galectin-9 axis in lung adenocarcinoma cells
by: Yunjia Dong, et al.
Published: (2025-01-01)

Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma
by: Fushan Gao, et al.
Published: (2024-12-01)

Role of alpha-fetoprotein in complex diagnostics of progressing course of chronic hepatitis B and C
by: I. A. Belavina, et al.
Published: (2012-06-01)

Efficacy and fibrinogen correlations of defibrinogen therapy in idiopathic sudden sensorineural hearing loss
by: Bing Wang, et al.
Published: (2025-02-01)

SOX9: a key transcriptional regulator in organ fibrosis
by: Yishuo Li, et al.
Published: (2025-02-01)

Effects of perioperative treatment of resectable adenocarcinoma of esophagogastric junction by immunotherapy (Adebrelimab) combined with chemotherapy (XELOX): protocol for a single-center, open-labeled study (AEGIS trial, neoadjuvant immunochemotherapy)
by: Yingyi Li, et al.
Published: (2025-02-01)

Risk factors for growth retardation in children with juvenile idiopathic arthritis: a case-control study
by: Ying Zhang, et al.
Published: (2025-01-01)

Association of valproate use and hippocampal atrophy in idiopathic generalized epilepsy
by: Xiang Huang, et al.
Published: (2025-01-01)

Beyond Tumors: The Pivotal Role of TRIM Proteins in Chronic Non-Tumor Lung Diseases
by: Huang X, et al.
Published: (2025-02-01)

Efficacy of Tui Na in idiopathic constipation in children with cerebral palsy: a randomized controlled clinical trial
by: Huijuan Wang, et al.
Published: (2025-01-01)

It’s about TIME – Gal-9 as a potential immunotherapeutic target in pancreatic ductal adenocarcinoma
by: Christin Knickmeier, et al.
Published: (2025-01-01)

Comparative efficacy of programmed death ligand 1 inhibition and chemotherapy in advanced gastric or gastroesophageal junction cancer with combined positive score – a meta-analysis
by: Zakari Shaibu, et al.
Published: (2024-10-01)

Livogrit mitigates ANIT-induced cholestasis-like symptoms in an in vivo model by curbing hepatic inflammation and regulating BAX, TGF-β, MMP-9 and α-SMA gene expression
by: Acharya Balkrishna, et al.
Published: (2025-02-01)

Long-term survival with pemetrexed-based chemotherapy in a patient with metastatic lung adenocarcinoma of unclear primary origin harboring MTHFR C677T(T/T) mutation: a case report
by: Yuan Yu, et al.
Published: (2025-01-01)